Latest News...

  • 3/21/16...Immunetics' BacTx test helps Hospitals meet FDA updated draft guidance ...
  • 2/23/16...Immunetics, Inc. announces the launch of its new MycoDx™ assay for invasive fungal infection...
  • 8/15/13....FDA Approves Apheresis Platelet Claims for Immunetics' BacTx Rapid Test for Bacterial Contamination
  • 11/26/12....Immunetics, Inc. Names John Yonkin as CEO
  • 10/2/12....SeraCare and Immunetics receive NIH Grant for Recent HIV Infection Rapid Test and Incidence Panels
  • 10/2/12....Leading Physicians to Discuss “Advances in Bacterial Testing of Platelets: BacTx Field Experience” at American Association of Blood Banks (AABB) Annual Meeting
  • 9/10/12....Immunetics Receives $3.7 Million NIH Contract for Babesia Blood Screening Test
  • 6/12/12....Immunetics receives FDA clearance for BacTx Rapid Test for Bacterial Contamination of Platelets

About Immunetics

Since 1987, Immunetics has been creating unique diagnostics that detect some of the most virulent diseases and pathogens known. We research, develop, and bring to market viable products which healthcare professionals worldwide rely on to address pressing problems in public health.

Immunetics. Dedicated to health through science.

  • More About Immunetics
  • View All News
  • Contact Us

Target for Diagnosis or Detection

Bloodborne Pathogens